openPR Logo
Press release

Future of Glycated Albumin Assay Market: Trends, Revenue Insights & Competitive Analysis | Biocompare, EFK Diagnostics, Biomatik, Weldon Biotech India Private Limited, Beijing Strong Biotechnologies Inc

11-06-2025 01:02 PM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Glycated Albumin Assay Market

Glycated Albumin Assay Market

Glycated Albumin Assay market size reached US$470.79 Million in 2024 from US$434.85 Million in 2023 and is expected to reach US$962.12 Million by 2033, growing at a CAGR of 8.15% during the forecast period 2025-2033.

DataM Intelligence has released its latest report on the "Glycated Albumin Assay Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR projections, and emerging opportunities that help businesses identify growth areas and build effective strategies. Backed by data-driven insights and future outlook, this study serves as a valuable resource for companies looking to stay competitive and capitalize on market potential.

According to the International Diabetes Federation, approximately 589 million adults aged 20-79 were living with diabetes in 2024, with this number projected to increase to around 853 million by 2050. Additionally, a significant portion remains undiagnosed, with an estimated 252 million adults unaware of their condition.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/glycated-albumin-assay-market?kb

Key Market Highlights (Rephrased):

North America leads the Glycated Albumin Assay market, capturing the largest revenue share of 38.54% in 2024.

The Asia Pacific region is the fastest-growing market, expected to register a CAGR of 10.27% during the forecast period.

By application type, the type 2 diabetes segment dominated the market with a 48.84% revenue share in 2024

Key Player:

Asahi Kasei Pharma Corporation, Hzymes Biotechnology Co., Ltd., DxGen Corp., Abbexa Ltd., Biocompare, EFK Diagnostics, Biomatik, Weldon Biotech India Private Limited, Beijing Strong Biotechnologies Inc., Diazyme Laboratories Inc

United States: Recent Industry Developments - Glycated Albumin Assay

✅ October 2025: Diagnostic firms introduced point-of-care glycated albumin testing kits for diabetes monitoring.
✅ September 2025: Clinical labs integrated GA assays alongside HbA1c for improved glycemic assessment.
✅ August 2025: FDA cleared automated analyzers enhancing test accuracy and throughput.

Japan: Recent Industry Developments
✅ October 2025: Japanese researchers published new reference ranges for glycated albumin in diabetic populations.
✅ September 2025: Hospitals adopted GA assays for routine checkups in metabolic clinics.
✅ August 2025: Instrument manufacturers upgraded reagent stability and assay precision standards.

Forecast Projection:

The global Glycated Albumin Assay market is set to witness strong growth from 2025 to 2032. After maintaining steady momentum in 2024, the market is expected to accelerate as key industry players implement strategic initiatives to boost adoption. Companies that adapt to these emerging trends will be well-positioned to capture new opportunities and enhance their revenue potential throughout the forecast period.

Market Intelligence Research Process:

The Glycated Albumin Assay Market Report by DataM Intelligence offers a comprehensive analysis built on a mix of primary and secondary research. It explores key factors driving the industry, including government policies, market trends, competitive landscape, technological advancements, and upcoming innovations. This in-depth study uncovers both growth opportunities and potential challenges, helping businesses navigate market fluctuations and make data-driven decisions for sustainable success.

Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @ https://www.datamintelligence.com/buy-now-page?report=glycated-albumin-assay-market?kb

Key Segments:

By Application: (Prediabetes, Type 1 Diabetes, Type 2 Diabetes)

By End-User: (Hospital and Diabetes Care Centers, Diagnos, tic Laboratories, Other End Users)

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/glycated-albumin-assay-market?kb

Latest M&A

Lifecycle BioSciences acquired Everest Biotech in 2025 to enhance antibody-based glycated albumin assay offerings and expand R&D capabilities.​

Diazyme Laboratories partnered with Carolina Liquid Chemistries to advance enzyme- and immunoassay-based glycated albumin reagents and testing platforms.​

Key players including Asahi Kasei, Lucica, and Weldonbiotech continue strategic collaborations to innovate and increase market penetration.​

Investment trends focus on expanding point-of-care testing and AI-driven assay development for diabetic care centers and hospitals.

Have any Query We Will Provide in Detailed @ https://www.datamintelligence.com/enquiry/glycated-albumin-assay-market?kb

Latest FDA Approvals

The FDA granted approval in 2025 to several glycated albumin assays used in diabetes management, with ongoing expansions in approved indications for diabetic nephropathy and chronic kidney disease.​

Novel glycated albumin assay kits with enhanced analytic performance and scalability have received regulatory clearance for clinical laboratories and point-of-care settings.​

Reimbursement

Despite clinical benefits, inconsistent reimbursement and lack of uniform coverage policies for glycated albumin assays limit widespread adoption, particularly outside the US and Europe.​

Medicare and private insurers provide limited coverage compared to HbA1c, impacting test utilization rates and investment in advanced assay platforms.​

Efforts to include glycated albumin in standard diabetes management guidelines and payer frameworks are ongoing to improve reimbursement and patient access.

Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Future of Glycated Albumin Assay Market: Trends, Revenue Insights & Competitive Analysis | Biocompare, EFK Diagnostics, Biomatik, Weldon Biotech India Private Limited, Beijing Strong Biotechnologies Inc here

News-ID: 4257360 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Breakthrough Nutritional Ingredients Poised to Capture USD 325.4 Billion by 2031, Driven by Supplements and Functional Foods Demand | DataM Intelligence
Breakthrough Nutritional Ingredients Poised to Capture USD 325.4 Billion by 2031 …
The Global Nutritional Ingredients Market was valued at USD 182.5 billion in 2022 and is projected to reach USD 325.4 billion by 2031, growing at a CAGR of 7.5% during the forecast period 2024-2031. This robust growth is driven by a profound and global consumer shift towards health and wellness, the accelerating adoption of vegan and plant-based lifestyles, an aging global population seeking preventative nutrition, and the rapid expansion of
United States Aluminum Powder Market to Hit $3.71 Billion by 2032 | Leading companies - Toyal America Inc, Hunan Ningxiang Jiweixin Metal Powder Co., Ltd., ECKA Granules
United States Aluminum Powder Market to Hit $3.71 Billion by 2032 | Leading comp …
Leander, Texas and Tokyo, Japan - Dec.10.2025 As per DataM intelligence research report" Global Aluminum Powder Market Size reached US$ 7.32 billion in 2024 and is expected to reach US$ 12.39 billion by 2032, growing with a CAGR of 6.80% during the forecast period 2025-2032." Lightweight materials demand and additive manufacturing growth are boosting aluminum powder usage. Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/aluminum-powder-market?Prasad United States: Recent Industry
North America Non-Steroidal Anti-Inflammatory Drugs Market to Reach $17.27 Billion by 2033 | Leading companies - Bayer AG, Haleon group of companies, Kenvue, Teva Pharmaceutical Industries Ltd
North America Non-Steroidal Anti-Inflammatory Drugs Market to Reach $17.27 Billi …
Leander, Texas and Tokyo, Japan - Dec.10.2025 As per DataM intelligence research report" The North America non-steroidal anti-inflammatory drugs market size reached US$ 8.34 billion in 2024 and is expected to reach US$ 17.27 billion by 2033, growing at a CAGR of 7.6% during the forecast period 2025-2033." Chronic pain prevalence and OTC self-care trends continue to strengthen the NSAIDs market. Download your exclusive sample report today: (corporate email gets priority access):
United States Gene Therapy Market to Hit $6510.45 Million by 2033 | Leading companies - Alnylam Pharmaceuticals, Inc., NOVARTIS AG, Sarepta Therapeutics, Inc.
United States Gene Therapy Market to Hit $6510.45 Million by 2033 | Leading comp …
Leander, Texas and Tokyo, Japan - Dec.10.2025 As per DataM intelligence research report" The US Gene Therapy Market Size reached US$ 2,812.92 million in 2024 and is expected to reach US$ 21,701.51 million by 2033, growing at a CAGR of 23.5 % during the forecast period 2025-2033." Advances in viral vectors and precision medicine are driving rapid progress in the US gene therapy market. Download your exclusive sample report today: (corporate

All 5 Releases


More Releases for Glycated

Glycated Haemoglobin Testing Equipment Market Size 2024 to 2031.
Market Overview and Report Coverage Glycated Haemoglobin Testing Equipment is used to measure the level of glycated hemoglobin in the blood, which is a crucial indicator for managing diabetes. The market for glycated haemoglobin testing equipment is expected to witness significant growth in the coming years, with a projected CAGR of 8.60% during the forecasted period. The increasing prevalence of diabetes worldwide, coupled with the rising awareness about the
Glycated Hemoglobin Testing Market : Lucrative Opportunities
Organizations fabricating basic diagnostic gadgets are concentrating on encouraging items for viable tests. The utilization of glycated hemoglobin during detection of diabetes illness, mellitus keeps on picking up pace, making an enduring interest for glycated hemoglobin testing. The current report provide details regarding the worldwide glycated hemoglobin testing market. It conveys a figured point of view towards developing interest regarding these diagnosis in detecting of predominant issue, for example, diabetes.
Glycated Albumin Market
Market players and various research organisations are engaged in developing novel diagnostic tests using glycated albumin in order to meet increasing demand from end-use industries. For instance, in 2016, according to a study published in journal Nephrology Dialysis Transplantation reported that glycated albumin might provide a valuable alternative for predicting mortality in diabetic patients on hemodialysis. Furthermore, leading players in the market are focused on new product launches and its
Glycated Albumin Market - Size, Share, Trends, and Forecast
Global Glycated Albumin Market, by Product Type (Human Glycated Albumin and Animal Glycated Albumin), by Application (Diagnosis (Prediabetes, Type 1 Diabetes, and Type 2 Diabetes)) and Research), by End User (Hospitals/Clinics, Diagnostic Centers, Research Institutes, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ XX Mn in 2017 and is projected to exhibit a CAGR of XX% over the
Global Glycated Albumin Market 2017 : Exocell, BSBE, Medicalsystem, DIAZYME
Glycated Albumin A market study based on the " Glycated Albumin Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Glycated Albumin Market 2017’. The research report analyses the historical as well as present performance of the worldwide Glycated Albumin industry, and makes predictions on the future status of Glycated Albumin market on the basis of this analysis. Get Free Sample Copy of Report Here
Global Glycated Haemoglobin Testing Market
The Glycated Haemoglobin Testing Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Haemoglobin is the red protein in blood cells which carry oxygen around the body. Haemoglobin A1c is a chemical form of glycated haemoglobin in order to test glucose level in